vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $196.0M, roughly 1.7× Axsome Therapeutics, Inc.). Revolve Group, Inc. runs the higher net margin — 5.7% vs -14.6%, a 20.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 10.4%). Revolve Group, Inc. produced more free cash flow last quarter ($-13.3M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 9.5%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
AXSM vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $324.4M |
| Net Profit | $-28.6M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | -13.8% | 6.3% |
| Net Margin | -14.6% | 5.7% |
| Revenue YoY | 65.0% | 10.4% |
| Net Profit YoY | 61.9% | 50.4% |
| EPS (diluted) | $-0.55 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $324.4M | ||
| Q3 25 | $171.0M | $295.6M | ||
| Q2 25 | $150.0M | $309.0M | ||
| Q1 25 | $121.5M | $296.7M | ||
| Q4 24 | $118.8M | $293.7M | ||
| Q3 24 | $104.8M | $283.1M | ||
| Q2 24 | $87.2M | $282.5M | ||
| Q1 24 | $75.0M | $270.6M |
| Q4 25 | $-28.6M | $18.6M | ||
| Q3 25 | $-47.2M | $21.2M | ||
| Q2 25 | $-48.0M | $10.2M | ||
| Q1 25 | $-59.4M | $11.8M | ||
| Q4 24 | $-74.9M | $12.3M | ||
| Q3 24 | $-64.6M | $11.0M | ||
| Q2 24 | $-79.3M | $15.4M | ||
| Q1 24 | $-68.4M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | -13.8% | 6.3% | ||
| Q3 25 | -27.0% | 7.1% | ||
| Q2 25 | -24.5% | 5.8% | ||
| Q1 25 | -46.9% | 5.0% | ||
| Q4 24 | -61.1% | 3.9% | ||
| Q3 24 | -59.8% | 5.0% | ||
| Q2 24 | -89.5% | 5.8% | ||
| Q1 24 | -89.7% | 3.4% |
| Q4 25 | -14.6% | 5.7% | ||
| Q3 25 | -27.6% | 7.2% | ||
| Q2 25 | -32.0% | 3.3% | ||
| Q1 25 | -48.9% | 4.0% | ||
| Q4 24 | -63.1% | 4.2% | ||
| Q3 24 | -61.7% | 3.9% | ||
| Q2 24 | -91.0% | 5.4% | ||
| Q1 24 | -91.1% | 4.0% |
| Q4 25 | $-0.55 | $0.27 | ||
| Q3 25 | $-0.94 | $0.29 | ||
| Q2 25 | $-0.97 | $0.14 | ||
| Q1 25 | $-1.22 | $0.16 | ||
| Q4 24 | $-1.54 | $0.18 | ||
| Q3 24 | $-1.34 | $0.15 | ||
| Q2 24 | $-1.67 | $0.21 | ||
| Q1 24 | $-1.44 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $292.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $512.5M |
| Total Assets | $689.8M | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $292.3M | ||
| Q3 25 | $325.3M | $315.4M | ||
| Q2 25 | $303.0M | $310.7M | ||
| Q1 25 | $300.9M | $300.8M | ||
| Q4 24 | $315.4M | $256.6M | ||
| Q3 24 | $327.3M | $252.8M | ||
| Q2 24 | $315.7M | $244.7M | ||
| Q1 24 | $331.4M | $273.4M |
| Q4 25 | $88.3M | $512.5M | ||
| Q3 25 | $73.7M | $490.2M | ||
| Q2 25 | $73.1M | $468.6M | ||
| Q1 25 | $53.2M | $453.4M | ||
| Q4 24 | $57.0M | $437.8M | ||
| Q3 24 | $92.9M | $420.8M | ||
| Q2 24 | $102.9M | $405.8M | ||
| Q1 24 | $144.0M | $389.9M |
| Q4 25 | $689.8M | $765.0M | ||
| Q3 25 | $669.3M | $751.3M | ||
| Q2 25 | $639.8M | $722.9M | ||
| Q1 25 | $596.7M | $713.9M | ||
| Q4 24 | $568.5M | $665.5M | ||
| Q3 24 | $561.5M | $670.9M | ||
| Q2 24 | $548.2M | $657.8M | ||
| Q1 24 | $545.7M | $650.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-10.2M |
| Free Cash FlowOCF − Capex | $-18.7M | $-13.3M |
| FCF MarginFCF / Revenue | -9.6% | -4.1% |
| Capex IntensityCapex / Revenue | 0.0% | 1.0% |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-10.2M | ||
| Q3 25 | $1.0M | $11.8M | ||
| Q2 25 | $-32.4M | $12.6M | ||
| Q1 25 | $-43.4M | $45.1M | ||
| Q4 24 | $-26.2M | $3.9M | ||
| Q3 24 | $-18.6M | $9.1M | ||
| Q2 24 | $-30.1M | $-24.7M | ||
| Q1 24 | $-53.5M | $38.4M |
| Q4 25 | $-18.7M | $-13.3M | ||
| Q3 25 | $988.0K | $7.5M | ||
| Q2 25 | $-32.4M | $10.4M | ||
| Q1 25 | $-43.7M | $43.4M | ||
| Q4 24 | $-26.2M | $2.1M | ||
| Q3 24 | $-18.7M | $8.0M | ||
| Q2 24 | $-30.2M | $-25.7M | ||
| Q1 24 | $-53.6M | $36.7M |
| Q4 25 | -9.6% | -4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | -21.6% | 3.4% | ||
| Q1 25 | -36.0% | 14.6% | ||
| Q4 24 | -22.1% | 0.7% | ||
| Q3 24 | -17.9% | 2.8% | ||
| Q2 24 | -34.6% | -9.1% | ||
| Q1 24 | -71.4% | 13.5% |
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.3% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
